Quantcast

Latest BRCA1 Stories

2014-01-11 23:01:48

The US Supreme court ruled recently that the test patent is no longer valid causing pricing for Genetic testing to plummet. Thousand Oaks, CA (PRWEB) January 11, 2014 BRCA gene is currently the most well known breast cancer (and ovarian cancer) gene. Women with a BRCA1 and/or BRCA2 gene mutation are up to eight times more likely to develop breast malignancy than women without. In other words, the lifetime risk for getting breast cancer is up to 85%. If and when cancer happens, it tends...

New Online Database Sheds Light On Gene Patenting Process
2013-12-08 06:29:33

redOrbit Staff & Wire Reports – Your Universe Online Researchers from Cambria, a non-profit biotech research organization, and the Queensland University of Technology (QUT), have developed a new online database revealing which organizations have applied for patents related to genes and proteins in living organisms. The open-sourced PatSeq registry, which is the subject of a paper published in last week’s edition of Nature Biotechnology, currently holds over 120 million DNA...

2013-11-27 15:48:08

Women who are members of families with BRCA2 mutations but who test negative for the family-specific BRCA2 mutations are still at greater risk for developing breast cancer compared with women in the general population, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. Women with certain mutations in their BRCA1 or BRCA2 genes are at increased risk for breast cancer. However, if a woman who comes...

2013-10-17 16:37:52

Researchers announced today in the journal Lancet Oncology that they are well on the way to discovering why women with the faulty genes BRCA 1 and BRCA 2, one of which was inherited by the actress Angelina Jolie, develop breast and ovarian cancer rather than other cancers. The study, carried out by researchers at the UCL Department of Women's Cancer, found that abnormal levels of female hormones in the bloodstream could be the answer. The findings have already led to more research into...

2013-10-09 23:24:00

In honor of Breast Cancer Awareness Month, Fertility Centers of Illinois discusses genetic screening for breast cancer and fertility preservation during a breast cancer diagnosis. Chicago, IL (PRWEB) October 09, 2013 For some families with the BRCA1 gene mutation, the lifetime risk of breast cancer can be as high as 80 percent, with the average risk of breast cancer resulting from a BRCA1 or BRCA2 gene mutation ranging from 45 to 65 percent. Through advances in modern science, couples are...

2013-10-08 13:53:37

Technology as sensitive as standard methodology but more efficient, say researchers in the Journal of Molecular Diagnostics The recognition of a causal link between mutations in BRCA1 and BRCA2 genes and increased risk of developing breast and ovarian cancer has intensified the demand for genetic testing. Identifying mutations in these large genes by conventional methods can be time consuming and costly. A report in the November issue of the Journal of Molecular Diagnostics describes a new...

2013-10-07 23:25:11

A New York infertility treatment and research center earns a patent for a unique method of reducing the risk and spread of breast and ovarian cancer in women. New York, New York (PRWEB) October 07, 2013 The Center for Human Reproduction (CHR), a leading fertility research and treatment center in New York City, has been awarded a U.S. patent by the U.S. Patent and Trademark Office regarding use of FMR1 gene inhibitors as a method of reducing the risk of and/or spread of breast or ovarian...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related